Department of Gastroenterological Surgery, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004, Japan.
Department of Biostatistics, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004, Japan.
Eur J Surg Oncol. 2019 May;45(5):761-768. doi: 10.1016/j.ejso.2018.10.532. Epub 2018 Oct 24.
The World Health Organization (WHO) proposed an integrated classification for intraductal papillary neoplasm of the bile duct (IPNB) in 2010. However, IPNB reportedly shows considerable geographic variation. This Japanese single-institution study examined outcomes of surgery for IPNB and the prognostic impact of immunohistochemical mucin expression patterns.
Patients with IPNB were identified from 413 patients who underwent curative-intent surgery for biliary tract (excluding gallbladder) neoplasms from 1992 to 2016 by retrospective macro- and microscopic reevaluation of resected specimens. Their clinicopathological variables were analyzed.
Twenty-two (5%) 2010 WHO classification-based patients with IPNB were identified. The other 391 patients had common-type cholangiocarcinoma. The histopathological grade was low/intermediate in 2 patients (9%), high in 8 (36%), and invasive carcinoma (ICa) in 12 (55%). The 10-year overall survival rate was 100% in 10 patients with low-high grade IPNB and 69% in 12 patients with ICa. These rates were significantly (p = 0.018) or marginally (p = 0.089) better than that (38%) of 391 other-cholangiocarcinoma patients. In the 12 patients with ICa, R0 or R1 resection, MUC5AC, and MUC6 expression significantly affected survival. Notably, all seven patients with ICa exhibiting MUC5AC expression survived throughout the study period, while four of five patients with ICa who did not exhibit MUC5AC expression died of recurrence (with vs. without MUC5AC: 10-year overall survival, 100% vs. 60%, respectively; p = 0.018).
Our 24-year, single institution's experience suggests that Japanese patients with IPNB favorably respond to surgery, even with ICa. MUC5AC and MUC6 expression may be predictive of favorable outcomes.
世界卫生组织(WHO)于 2010 年提出了胆管内乳头状肿瘤(IPNB)的综合分类。然而,据报道,IPNB 存在相当大的地域差异。本项日本单机构研究探讨了 IPNB 手术治疗的结果以及免疫组织化学黏蛋白表达模式的预后影响。
通过对 1992 年至 2016 年间 413 例接受胆道(不包括胆囊)肿瘤根治性手术的患者的标本进行回顾性宏观和微观再评估,确定了 IPNB 患者。分析了他们的临床病理变量。
确定了 22 例(5%)2010 年 WHO 分类为 IPNB 的患者。其他 391 例患者为普通型胆管癌。2 例(9%)组织学分级为低/中,8 例(36%)为高,12 例(55%)为浸润性癌(ICa)。10 年总生存率在低-高级 IPNB 组的 10 例患者中为 100%,在 ICa 组的 12 例患者中为 69%。这些生存率显著(p=0.018)或边缘显著(p=0.089)优于 391 例其他胆管癌患者(38%)。在 12 例 ICa 患者中,R0 或 R1 切除、MUC5AC 和 MUC6 表达显著影响生存。值得注意的是,所有 7 例表现出 MUC5AC 表达的 ICa 患者在整个研究期间均存活,而 5 例未表现出 MUC5AC 表达的 ICa 患者中有 4 例因复发而死亡(有 vs. 无 MUC5AC:10 年总生存率分别为 100%和 60%;p=0.018)。
本机构 24 年的经验表明,日本的 IPNB 患者对手术治疗反应良好,即使是 ICa 患者也是如此。MUC5AC 和 MUC6 表达可能是预后良好的预测因素。